Compounds > lamotrigine

lamotrigine and glycine

lamotrigine has been researched along with glycine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Attwell, PJ; Bradford, HF; Croucher, MJ; Jane, DE; Singh Kent, N1
Eriksson, AS; O'Connor, WT1
Bassani, F; Bergamaschi, M; Bregola, G; Pietra, C; Rondelli, I; Simonato, M; Villetti, G1
Bergamaschi, M; Buzzi, A; Pietra, C; Simonato, M; Villetti, G; Zucchini, S1

Other Studies

7 other study(ies) available for lamotrigine and glycine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV).
    Brain research, 1998, Sep-14, Volume: 805, Issue:1-2

    Topics: Amygdala; Animals; Anticonvulsants; Aspartic Acid; Cerebral Cortex; Cyclopropanes; Glutamic Acid; Glycine; Kindling, Neurologic; Lamotrigine; Male; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Seizures; Synaptosomes; Triazines

1998
Analysis of CSF amino acids in young patients with generalised refractory epilepsy during an add-on study with lamotrigine.
    Epilepsy research, 1999, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Amino Acids; Anticonvulsants; Aspartic Acid; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Epilepsy, Generalized; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Humans; Lamotrigine; Male; Treatment Outcome; Triazines

1999
Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
    Neuropharmacology, 2001, Volume: 40, Issue:7

    Topics: Animals; Anticonvulsants; Dizocilpine Maleate; Drug Evaluation, Preclinical; Epilepsy; Excitatory Amino Acid Antagonists; Glycine; Indans; Kindling, Neurologic; Lamotrigine; Male; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Triazines

2001
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist.
    Neuroreport, 2002, Nov-15, Volume: 13, Issue:16

    Topics: Animals; Anticonvulsants; Cell Death; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; Histological Techniques; Indans; Kainic Acid; Lamotrigine; Male; Mice; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Seizures; Triazines

2002